Johnson & Johnson and Bayer AG didn’t defectively design Xarelto blood thinner, federal jury in Mississippi ruled Aug. 18. (Mingo v. Janssen Research and Development LLC, E.D. La., 15-cv-3469, 8/18/17) (In RE Xarelto Products Liability Litigations, E.D. La., 14-MD-2592, 8/18/17).
Mississippi grandmother, Dora Mingo, had accused the companies of misleading her doctors about the. drug’s health risks.
The verdict is the companies’ third-straight win in cases over Xarelto, which is developed jointly by J&J’s unit Janssen and Bayer.
“The jury’s decision reflects the facts of this case and the appropriateness of Xarelto,” said Janssen’s Sarah Freeman....